Literature DB >> 18392609

Gene profiling in human blood leucocytes during recovery from septic shock.

Didier Payen1, Anne-Claire Lukaszewicz, Ioulia Belikova, Valérie Faivre, Catherine Gelin, Stefan Russwurm, Jean-Marie Launay, Nicolas Sevenet.   

Abstract

OBJECTIVE: To assess blood leucocytes gene profiling during recovery phase of septic shock; to test the relation between encoding gene expression and protein level. STUDY
DESIGN: Gene expression levels were studied at days 0, 1, 7 and 28 (D0, 1, 7 and 28) on a dedicated microarray of 340 genes involved in inflammatory processes. SETTINGS: 16-bed intensive care unit, Lariboisière University hospital. PATIENTS: Seventeen septic shock patients enrolled when at least one additional organ dysfunction occurred. MEASUREMENTS AND
RESULTS: Changes over time were compared with D0 via the ratio Dx/D0. The time-related gene expression study showed significant changes in ten genes. Among them, S100A8 and S100A12 had a reduced expression over time compared with D0, whereas CD74's expression increased. The microarray results were validated by RT-qPCR for four genes. The S100A8 plasma levels decrease along recovery in parallel with the gene expression decrease. The CD74 gene expression evolution significantly correlated with HLA-DR monocyte expression.
CONCLUSIONS: These results are the first description of variations in expression of key inflammatory genes in the course of the septic shock recovery period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392609     DOI: 10.1007/s00134-008-1048-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria.

Authors:  Jennifer C Boldrick; Ash A Alizadeh; Maximilian Diehn; Sandrine Dudoit; Chih Long Liu; Christopher E Belcher; David Botstein; Louis M Staudt; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 2.  Invariant chain, a chain of command.

Authors:  Didi Matza; Anat Kerem; Idit Shachar
Journal:  Trends Immunol       Date:  2003-05       Impact factor: 16.687

3.  Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide.

Authors:  Karen Vandal; Pascal Rouleau; Annie Boivin; Carle Ryckman; Mariève Talbot; Philippe A Tessier
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  Sepsis in European intensive care units: results of the SOAP study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

5.  Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.

Authors:  Alexandre Pachot; Guillaume Monneret; Aurélie Brion; Fabienne Venet; Julien Bohé; Jacques Bienvenu; Bruno Mougin; Alain Lepape
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

6.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Authors:  Guillaume Monneret; Marie-Emmanuelle Finck; Fabienne Venet; Anne-Lise Debard; Julien Bohé; Jacques Bienvenu; Alain Lepape
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

7.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

8.  Probing the S100 protein family through genomic and functional analysis.

Authors:  Timothy Ravasi; Kenneth Hsu; Jesse Goyette; Kate Schroder; Zheng Yang; Farid Rahimi; Les P Miranda; Paul F Alewood; David A Hume; Carolyn Geczy
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

9.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Authors:  E Abraham; R Wunderink; H Silverman; T M Perl; S Nasraway; H Levy; R Bone; R P Wenzel; R Balk; R Allred
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

10.  Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock.

Authors:  Vincent Caille; Jean-Daniel Chiche; Noureddine Nciri; Christine Berton; Sébastien Gibot; Bernadette Boval; Didier Payen; Jean-Paul Mira; Alexandre Mebazaa
Journal:  Shock       Date:  2004-12       Impact factor: 3.454

View more
  31 in total

1.  Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.

Authors:  Brittany E Thames; James W Barr; Jan S Suchodolski; Jörg M Steiner; Romy M Heilmann
Journal:  J Vet Diagn Invest       Date:  2019-06-06       Impact factor: 1.279

Review 2.  Alarmins: awaiting a clinical response.

Authors:  James K Chan; Johannes Roth; Joost J Oppenheim; Kevin J Tracey; Thomas Vogl; Marc Feldmann; Nicole Horwood; Jagdeep Nanchahal
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 3.  Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.

Authors:  E V Schrezenmeier; J Barasch; K Budde; T Westhoff; K M Schmidt-Ott
Journal:  Acta Physiol (Oxf)       Date:  2016-08-25       Impact factor: 6.311

Review 4.  The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness.

Authors:  Kevin C Ma; Edward J Schenck; Maria A Pabon; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

Review 5.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

6.  Immunity check should be performed for all patients with septic shock? No.

Authors:  Didier Payen
Journal:  Intensive Care Med       Date:  2020-03-02       Impact factor: 17.440

Review 7.  Cytokine storm and sepsis disease pathogenesis.

Authors:  Benjamin G Chousterman; Filip K Swirski; Georg F Weber
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 8.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Assessing the human immune system through blood transcriptomics.

Authors:  Damien Chaussabel; Virginia Pascual; Jacques Banchereau
Journal:  BMC Biol       Date:  2010-07-01       Impact factor: 7.431

10.  The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice.

Authors:  Ying Sun; Yu Lu; Christopher G Engeland; Sara C Gordon; Herve Y Sroussi
Journal:  Mol Immunol       Date:  2012-11-03       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.